1887

Chapter 43 : and Related Genera

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

and Related Genera, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap43-1.gif /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap43-2.gif

Abstract:

The genera , , , , and belong to the family Alcaligenaceae (order in the β subclass of the ). The genus was proposed for a set of strains phenotypically resembling that were classified as or as belonging to at least one other species. Virulence factors of bordetellae can be classified as adhesins, autotransporters (i.e., filamentous hemagglutinin [FHA], fimbriae [FIM], and pertactin [PRN]), and toxins (i.e., pertussis toxin [PT], adenylate cyclase toxin, and lipopolysaccharide [LPS]). For other bordetellae, normal microbiological transport media seem to be suitable for transport. Similarly, , , , and species can survive in a wide range of environments and at various temperatures. Commercial multiplex PCRs for the detection of various respiratory agents, including bordetellae, are available. Members of the genus can be separated from related species by their inability to assimilate phenyl acetate. and are susceptible in vitro to a range of antibiotics, including penicillins, macrolides, ketolides, quinolones, and other antibiotics, including tetracyclines, chloramphenicol, and trimethoprim-sulfamethoxazole, whereas they are resistant to most oral cephalosporins. Antimicrobial sensitivity testing of the isolates should be interpreted in accordance with criteria for other infrequently isolated and fastidious nonfermentative gram-negative rods.

Citation: Wirsing von König C, Riffelmann M, Coenye T. 2011. and Related Genera, p 739-750. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch43
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Growth of on RL medium.

Citation: Wirsing von König C, Riffelmann M, Coenye T. 2011. and Related Genera, p 739-750. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch43
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816728.chap43
1. Aisenberg, G.,, K. V. Rolston,, and A. Safdar. 2004. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer 101: 2134 2140.
2. Altunaiji, S.,, R. Kukuruzovic,, N. Curtis,, and J. Massie. 2. 2007. Antibiotics for whooping cough (pertussis). Cochrane Database Syst. Rev. 18: CD004404.
3. Antila, M.,, Q. He,, C. de Jong,, I. Aarts,, H. Verbakel,, S. Bruistenm,, S. Keller,, M. Haanperä,, J. Mäkinen,, E. Eerola,, M. J. Viljanen,, J. Mertsola,, and A. van der Zee. 2006. Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J. Med. Microbiol. 55: 1043 1051.
4. Arvand, M.,, R. Feldhues,, M. Mieth,, T. Kraus,, and P. Vandamme. 2004. Chronic cholangitis caused by Bordetella hinzii in a liver transplant recipient. J. Clin. Microbiol. 42: 2335 2337.
5. Baughman, A. L.,, K. M. Bisgard,, K. M. Edwards,, D. Guris,, M. D. Decker,, K. Holland,, B. D. Meade,, and F. Lynn. 2004. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol. 11: 1045 1053.
6. Bizet, J.,, and C. Bizet. 1997. Strains of Alcaligenes faecalis from clinical material. J. Infect. 35: 167 169.
7. Bizet, C.,, F. Tekaia,, and A. Philippon. 1993. In-vitro susceptibility of Alcaligenes faecalis compared with those of other Alcaligenes spp. to antimicrobial agents including seven betalactams. J. Antimicrob. Chemother. 32: 907 910.
8. Bordet, J.,, and U. Gengou. 1906. Le microbe de la coqueluche. Ann. Inst. Pasteur 20: 48 68.
9. Bosch, A.,, A. Miñán,, C. Vescina,, J. Degrossi,, B. Gatti,, P. Montanaro,, M. Messina,, M. Franco,, C. Vay,, J. Schmitt,, D. Naumann,, and O. Yantorno. 2008. Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients. J. Clin. Microbiol. 46: 2535 2546.
10. Bosshard, P. P.,, R. Zbinden,, S. Abels,, B. Böddinghaus,, A. Altwegg,, and E. C. Böttger. 2006. 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting gram-negative bacteria in the clinical laboratory. J. Clin. Microbiol. 44: 1359 1366.
11. Brinig, M. M.,, C. A. Cummings,, G. N. Sanden,, P. Stefanelli,, A. Lawrence,, and D. A. Relman. 2006. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J. Bacteriol. 188: 2375 2382.
12. Burns, J. L.,, J. Emerson,, J. R. Stapp,, D. L. Yim,, J. Krzewinski,, L. Louden,, B. W. Ramsey,, and C. R. Clausen. 1998. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 27: 158 163.
13. Busse, H. J.,, and A. Stolz,. 2006. Achromobacter, Alcaligenes and related genera, p. 675 700. In M. Dworkin,, S. Falkow,, E. Rosenberg,, K.-H. Schleifer,, and E. Stackebrandt (ed.), The Prokaryotes, vol. 5. Springer, Heidelberg, Germany.
14. Cagney, M.,, P. B. McIntyre,, L. Heron,, A. Giammanco,, and C. R. MacIntyre. 2008. The relationship between pertussis symptomatology, incidence and serology in adolescents. Vaccine 26: 5547 5553.
15. Cattaneo, L. A.,, G. W. Reed,, D. H. Haase,, M. J. Wills,, and K. M. Edwards. 1996. The seroepidemiology of Bordetella pertussis infections: a study in persons ages 1-65 years. J. Infect. Dis. 173: 1256 1259.
16. CDC. 2007. Outbreaks of respiratory illness mistakenly attributed to pertussis—New Hampshire, Massachusetts, and Tennessee, 2004-2006. Morb. Mortal Wkly. Rep. 56: 837842.
17. Clarridge, J. E., III. 2004. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases . Clin. Microbiol. Rev. 17: 840 862.
18. Clermont, D.,, C. Harmant,, and C. J. Bizet. 2001. Identification of strains of Alcaligenes and Agrobacterium by a polyphasic approach. J. Clin. Microbiol. 39: 3104 3109.
19. Coenye, T.,, J. Goris,, T. Spiker,, P. Vandamme,, and J. J. LiPuma. 2002. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients, and description of Inquilinus limosus gen. nov. sp. nov. J. Clin. Microbiol. 40: 2062 2069.
20. Coenye, T.,, M. Vancanneyt,, M. Cnockaert,, E. Falsen,, J. Swings,, and P. Vandamme. 2003. Kerstersia gyiorum gen. nov., sp. nov., a novel Alcaligenes faecalis-like organism isolated from human clinical samples, and reclassification of Alcaligenes denitrificans Rüger and Tan 1983 as Achromobacter denitrificans comb. nov. Int. J. Syst. Evol. Microbiol. 53: 1825 1831.
21. Coenye, T.,, M. Vancanneyt,, E. Falsen,, J. Swings,, and P. Vandamme. 2003. Achromobacter insolitus sp. nov. and Achromobacter spanius sp. nov., from human clinical samples. Int. J. Syst. Evol. Microbiol. 53: 1819 1824.
22. Coenye, T.,, E. Vanlaere,, E. Samyn,, E. Falsen,, and P. Vandamme. 2005. Advenella incenata gen. nov., sp. nov., a novel member of the Alcaligenaceae, isolated from various clinical samples. Int. J. Syst. Evol. Microbiol. 55: 251 256.
23. Cosnes-Lambe, C.,, J. Raymond,, M. Chalumeau,, C. Pons-Catalano,, F. Moulin,, N. de Suremain,, H. Reglier-Pupet,, P. Lebon,, C. Poyart,, and E. Grimprel. 2008. Pertussis and respiratory syncytial virus infections. Eur. J. Pediatr. 167: 1017 1019.
24. Daxboeck, F.,, E. Goerzer,, P. Apfalter,, M. Nehr,, and R. Krause. 2004. Isolation of Bordetella trematum from a diabetic leg ulcer. Diabetes Med. 21: 1247 1248.
25. De Baets, F.,, P. Schelstraete,, S. Van Daele,, F. Haerynck,, and M. Vaneechoutte. 2007. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros. 6: 75 78.
26. Degand, N.,, E. Carbonelle,, B. Dauphin,, J. L. Beretti,, M. Le Bourgeois,, I. Sermet-Gaudelus,, C. Segonds,, P. Berche,, X. Nassif,, and A. Ferroni. 2008. Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. J. Clin. Microbiol. 46: 3361 3367.
27. De Melker, H. E.,, F. G. Versteegh,, M. A. Conyn-Van Spaendonck,, L. H. Elvers,, G. A. Berbers,, A. van der Zee,, and J. F. Schellekens. 2000. Specificity and sensitivity of high levels of immunoglobulin G antibodies to pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J. Clin. Microbiol. 38: 800 806.
28. Edwards, K. M.,, B. D. Meade,, M. D. Decker,, G. F. Reed,, M. B. Rennels,, M. C. Steinhoff,, E. L. Anderson,, J. A. Englund,, M. A. Pichichiero,, M. A. Deloria,, and A. Deforest. 1995. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 96: 548 557.
29. Fenollar, F.,, V. Roux,, A. Stein,, M. Drancourt,, and D. Raoult. 2006. Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections. J. Clin. Microbiol. 44: 1018 1028.
30. Fontana, C.,, M. Favaro,, M. Pellicioni,, E. S. Pistoia,, and C. Favalli. 2005. Use of the MicroSeq 500 16S rRNA gene-based sequencing for identification of bacterial isolates that commercial automated systems failed to identify. J. Clin. Microbiol. 43: 615 619.
31. Fry, N. K.,, O. Tzivra,, Y. T. Li,, A. Mcniff,, N. Doshi,, P. A. Maple,, N. S. Crowcroft,, E. Miller,, R. C. George,, and T. G. Harrison. 2004. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J. Med. Microbiol. 53: 519 525.
32. Fry, N. K.,, J. Duncan,, H. Malnick,, M. Warner,, A. J. Smith,, M. S. Jackson,, and A. Ayoub. 2005. Bordetella petrii clinical isolate . Emerg. Infect. Dis. 11: 1131 1133.
33. Fry, N. K.,, J. Duncan,, H. Malnick,, and P. M. Cockcroft. 2007. The first UK isolate of “ ansorpii” from an Bordetella immunocompromised patient. J. Med. Microbiol. 56: 993 995.
34. Fry, N. K.,, J. Duncan,, M. T. Edwards,, R. E. Tilley,, D. Chitvanis,, R. Harman,, H. Hammerton,, and L. Dalton. 2007. A UK clinical isolate of Bordetella hinzii from a patient with myelodysplastic syndrome. J. Med. Microbiol. 56: 1700 1703.
35. Fry, N. K.,, J. Duncan,, K. Wagner,, O. Tzivra,, N. Doshi,, D. J. Litt,, N. Crowcroft,, E. Miller,, R. C. George,, and T. G. Harrison. 2009. Role of PCR in the diagnosis of pertussis infection in infants: 5 years’ experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J. Med. Microbiol. 58: 1023 1029.
36. Gerlach, G.,, S. Janzen,, D. Beier,, and R. Gross. 2004. Functional characterization of the BvgAS two-component system of Bordetella holmesii. Microbiology 150: 3715 3729.
37. Giammanco, A.,, A. Nardone,, R. Pebody,, G. Kafatos,, N. Andrews,, A. Chiarini,, S. Taormina,, F. de Ory,, K. Prossenc,, B. Krize,, H. Hallander,, M. Ljungman,, E. Marva,, A. Tsakris,, D. O’Flanagan,, F. Schneider,, A. Griskevicius,, R. Vranckx,, and I. Karacs. 2008. European Sero-Epidemiology Network 2: standardization of immunoassay results for pertussis requires homogeneity of antigenic preparations. Vaccine 26: 4486 4493.
38. Gibello, A.,, A. L. Vela,, M. Martin,, A. Barra-Caracciolo,, P. Grenni,, and J. F. Fernandez-Garayzabal. 2009. Reclassification of the members of the genus Tetrathiobacter Ghosh et al. 2005 to the genus Advenella Coenye et al. 2005. Int. J. Syst. Evol. Microbiol. 59: 1914 1918.
39. Glupczynski, Y.,, W. Hansen,, J. Freney,, and E. Yourassowsky. 1988. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob. Agents Chemother. 32: 276 278.
40. Gómez-Cerezo, J.,, I. Suárez,, J. J. Ríos,, P. Peña,, M. J. García de Miguel,, M. de Joé,, O. Monteagudo,, P. Linares,, A. Barbado-Cano,, and J. J. Vázquez. 2003. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur. J. Clin. Microbiol. Infect. Dis. 22: 360 363.
41. Gross, R.,, C. A. Guzman,, M. Sebaiihia,, V. A. P. Martins dos Santos,, D. H. Pieper,, R. Koebnik,, M. Lechner,, D. Bartels,, J. Buhrmeister,, J. V. Choudhouri,, T. Ebensen,, L. Gaigalat,, S. Hermann,, A. N. Khachane,, C. Larisch,, S. Link,, B. Linke,, F. Meyer,, S. Mormann,, D. Nakunst,, C. Rückert,, S. Schneikerbekel,, K. Schulze,, F. J. Vorhölter,, T. Yevsa,, J. T. Engle,, W. E. Goldman,, A. Pühler,, U. B. Göbel,, A. Goesmann,, H. Blöcker,, O. Kaiser,, and R. Martinez-Arias. 2008. The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic bordetellae. BMC Genomics 9: 449.
42. Haberling, D. L.,, R. C. Holman,, C. D. Paddock,, and T. V. Murphy. 2009. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr. Infect. Dis. J. 28: 194 198.
43. Hallander, H. O.,, E. Reizenstein,, B. Renemar,, G. Rasmuson,, L. Mardin,, and P. Olin. 1993. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J. Clin. Microbiol. 31: 50 52.
44. Hallander, H.,, A. Advani,, M. Riffelmann,, C. H. Wirsing Von König,, V. Caro,, N. Guiso,, F. R. Mooi,, A. Gzyl,, M. S. Kaltoft,, N. K. Fry,, J. Mertsola,, and Q. He. 2007. Bordetella pertussis strain circulating in Europe in 1999 to 2004 as determined by pulsed field gel electrophoresis. J. Clin. Microbiol. 45: 3257 3261.
45. Harrington, A. T.,, J. A. Castellanos,, T. M. Ziedalski,, J. E. Clarridge III,, and B. T. Cookson. 2009. Isolation of Bordetella avium and novel Bordetella strain from patients with respiratory disease. Emerg. Infect. Dis. 15: 72 74.
46. Henry, D. A.,, M. E. Campbell,, J. J. LiPuma,, and D. P. Speert. 1997. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J. Clin. Microbiol. 35: 614 619.
47. Hewlett, E. L.,, G. M. Donato,, and M. C. Gray. 2006. Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making AMP. Mol. Microbiol. 59: 447 459.
48. Hijnen, M.,, Q. He,, R. Schepp,, P. van Gageldonk,, J. Mertsola,, F. R. Mooi,, and G. A. Berbers. 2008. Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin . Scand. J. Infect. Dis. 40: 92 104.
49. Hristov, A. C.,, P. G. Auwaerter,, M. Romagnoli,, and K. C. Caroll. 2008. Bordetella hinzii septicaemia in association with Epstein-Barr virus viremia and an Epstein-Barr virus-associated diffuse large B-cell lymphoma. Diagn. Microbiol. Infect. Dis. 61: 484 486.
50. Kadlec, K.,, J. Wiegand,, C. Kehrenberg,, and S. Schwarz. 2007. Studies on the mechanisms of beta-lactam resistance in Bordetella bronchiseptica. J. Antimicrob. Chemother. 59: 396 402.
51. Kanellopoulou, M.,, S. Pournaras,, H. Iglezos,, N. Skarmoutsou,, E. Papafrangas,, and A. N. Maniatis. 2004. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur. J. Clin. Microbiol. Infect. Dis. 23: 336 339.
52. Kattar, M. M.,, J. F. Chavez,, A. P. Limaye,, S. L. Rassoulianbarrett,, S. L. Yarfitz,, L. C. Carlson,, Y. Houze,, S. Swanzy,, B. L. Wood,, and B. T. Cookson. 2000. Application of 16S rRNA sequencing to identify Bordetella hinzii as the causative agent of fatal septicaemia. J. Clin. Microbiol. 38: 789 794.
53. Kay, S. E.,, R. A. Clark,, K. L. White,, and M. M. Peel. 2001. Recurrent Achromobacter piechaudii bacteremia in a patient with hematological malignancy. J. Clin. Microbiol. 39: 808 810.
54. Kersters, K.,, and J. De Ley,. 1984. Genus Alcaligenes Castellani and Chalmers 1919, 936 AL, p. 361 373. In N. R. Krieg, and J. G. Holt (ed.), Bergey’s Manual of Systematic Bacteriology, vol. 1. Williams & Wilkins Co., Baltimore, MD.
55. Kersters, K.,, K. H. Hinz,, A. Hertle,, P. Segers,, A. Lievens,, O. Siegmann,, and J. Deley. 1984. Bordetella avium sp. nov., isolated from the respiratory tracts of turkeys and other birds. Int. J. Syst. Bacteriol. 34: 56 70.
56. Kiredjian, M.,, B. Holmes,, K. Kersters,, I. Guilvout,, and J. De Ley. 1986. Alcaligenes piechaudii sp. nov., a new species from human clinical specimens and the environment. Int. J. Syst. Bacteriol. 36: 282 287.
57. Kiska, D. L.,, A. Kerr,, M. C. Jones,, J. A. Caracciolo,, B. Eskridge,, M. Jordan,, S. Miller,, D. Hughes,, N. King,, and P. H. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34: 886 891.
58. Ko, K. S.,, K. R. Pecj,, W. S. Oh,, N. Y. Lee,, J. H. Lee,, and J. H. Song. 2005. New species of Bordetella, Bordetella ansorpii sp. nov., isolated from the purulent exudate of an epidermal cyst . J. Clin. Microbiol. 43: 2516 2519.
59. Reference deleted.
60. Krzewinski, J. W.,, C. D. Nguyen,, J. M. Foster,, and J. L. burns. 2001. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J. Clin. Microbiol. 39: 3597 3602.
61. Le, T.,, J. D. Cherry,, S. J. Chang,, M. D. Knoll,, M. L. Lee,, S. Barenkamp,, D. Bernstein,, R. Edelman,, K. M. Edwards,, D. Greenberg,, W. Keitel,, J. Treanor,, and J. I. Ward. 2004. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J. Infect. Dis. 190: 535 544.
62. Liu, L.,, T. Coenye,, J. L. Burns,, P. W. Whitby,, T. L. Stull,, and J. J. Lipuma. 2002. rDNA-directed PCR for identification of Alcaligenes (Achromobacter) xylosoxidans recovered from cystic fibrosis sputum. J. Clin. Microbiol. 40: 1210 1213.
63. Loeffelholz, M. J.,, C. J. Thompson,, K. S. Long,, and M. J. R. Gilchrist. 2000. Detection of Bordetella holmesii using Bordetella pertussis IS 481 PCR assay. J. Clin. Microbiol. 38: 467.
64. Lynn, F.,, G. F. Reed,, and B. D. Meade. 1996. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin. Diagn. Lab. Immunol. 3: 689 700.
65. Mackenzie, F. M.,, S. V. Smith,, K. E. Milne,, K. Griffiths,, J. Legge,, and I. M. Gould. 2004. Antibiograms of resistant gram-negative bacteria from Scottish CF patients . J. Cyst. Fibros. 3: 151 157.
66. Mattoo, S.,, and J. D. Cherry. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18: 326 382.
67. Mertens, P. L.,, F. S. Stals,, E. W. Steyerberg,, and J. H. Richardus. 2007. Sensitivity and specificity of single IgA and IgG antibody concentrations for early diagnosis of pertussis in adults: an evaluation for outbreak management in public health practice. BMC Infect. Dis. 7: 53.
68. Moissenet, D.,, A. Baculard,, M. Valcin,, V. Marchand,, G. Tournier,, A. Garbarg-Chenon,, and H. Vu-Thien. 1997. Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin. Infect. Dis. 24: 274 275.
69. Moissenet, D.,, E. Bingen,, G. Arlet,, and H. Vu-Thien. 2005. Use of 16S rRNA gene sequencing for identification of Pseudomonas-like isolates from sputum of patients with cystic fibrosis . Pathol. Biol. (Paris) 53: 500 502.
70. Molina-Cabrillana, J.,, C. Santana-Reyes,, A. González-García,, A. Bordes-Benítez,, and I. Horcajada. 2007. Outbreak of Achromobacter xylosoxidans pseudobacteremia in a neonatal care unit related to contaminated chlorhexidine solution. Eur. J. Clin. Microbiol. Infect. Dis. 26: 435 437.
71. Moore, J. E.,, J. Xu,, b. C. Millar,, J. Courtney,, and J. S. Elborn. 2003. Development of a gram-negative selective agar (GNSA) for the detection of gram-negative microflora in sputa in patients with cystic fibrosis. J. Appl. Microbiol. 95: 160 166.
72. Mortensen, J. E.,, A. Brumbach,, and T. R. Shrycock. 1989. Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolates. Antimicrob. Agents Chemother. 33: 771 772.
73. Müller, F. M.,, J. E. Hoppe,, and, C. H. Wirsing von König. 1997. Diagnosis of pertussis: state of the art in 1997. J. Clin. Microbiol. 35: 2435 2443.
74. Muyldermans, G.,, O. Soetens,, M. Antoine,, S. Bruisten,, B. Vincart,, K. Doucet,, F. Populaire,, N. K. Fry,, P. Olcen,, J. M. Scheftel,, J. M. Senterre,, A. van der Zee,, M. Riffelmann,, D. Pierard,, and S. Lauwers. 2005. External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J. Clin. Microbiol. 43: 30 35.
75. Paddock, C. D.,, G. N. Sanden,, J. D. Cherry,, A. A. Gal,, C. Langston,, K. M. Tatti,, K. H. Wu,, C. S. Goldsmith,, P. W. Greer,, J. L. Montague,, M. T. Eliason,, R. C. Holman,, J. Guarner,, W. J. Shieh,, and S. R. Zaki. 2008. Pathology and pathogenesis of fatal Bordetella pertussis infections in infants. Clin. Infect. Dis. 47: 328 338.
76. Parkhill, J.,, M. Sebaihia,, A. Preston,, L. D. Murphy,, N. Thomson,, D. E. Harris,, M. T. Holden,, C. M. Churcher,, S. D. Bentley,, K. L. Mungall,, A. M. Cerdeño-Tárraga,, L. Temple,, K. James,, B. Harris,, M. A. Quail,, M. Achtman,, R. Atkin,, S. Baker,, D. Basham,, N. Bason,, I. Cherevach,, T. Chillingworth,, M. Collins,, A. Cronin,, P. Davis,, J. Doggett,, T. Feltwell,, A. Goble,, N. Hamlin,, H. Hauser,, S. Holroyd,, K. Jagels,, S. Leather,, S. Moule,, H. Norberczak,, S. O’Neil,, D. Ormond,, C. Price,, E. Rabbinowitsch,, S. Rutter,, M. Sanders,, D. Saunders,, K. Seeger,, S. Sharp,, M. Simmonds,, J. Skelton,, R. Squares,, S. Squares,, K. Stevens,, L. Unwin,, S. Whitehead,, B. G. Barrell,, And D. J. Maskell. 2003. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet. 35: 32 40.
77. Patriarca, P. A.,, R. J. Biellik,, G. Sanden,, D. G. Burstyn,, P. D. Mitchell,, P. R. Silverman,, J. P. Davis,, and C. R. Manclark. 1998. Sensitivity and specificity of clinical case definitions of pertussis. Am. J. Public Health 78: 833 836.
78. Pebody, R. G.,, N. J. Gay,, A. Giammanco,, S. Baron,, J. Schellekens,, A. Tischer,, R. M. Olander,, N. J. Andrews,, W. J. Edmunds,, H. Lecoeur,, D. Lévy-Bruhl,, P. A. Maple,, H. De Melker,, A. Nardone,, M. C. Rota,, S. Salmaso,, M. A. Conyn-van Spaendonck,, S. Swidsinski,, and E. Miller. 2005. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol. Infect. 133: 159 171.
79. Plotkin, S. (ed.). 2005. The global pertussis initiative. Pediatr. Infect. Dis. J. 24: S5 S98.
80. Raso, T.,, O. Bianco,, B. Grosso,, M. Zucca,, and D. Savoia. 2008. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS 116: 837 841.
81. Rath, B. A.,, K. B. Register,, J. Wall,, D. M. Sokol,, and R. B. Van Dyke. 2008. Persistent Bordetella bronchiseptica pneumonia in an immunocompetent infant and genetic comparison of clinical isolates with kennel cough vaccine strains. Clin. Infect. Dis. 46: 905 908.
82. Register, K. B.,, R. E. Sacco,, and G. E. Nordholm. 2003. Comparison of ribotyping and restriction enzyme analysis for inter- and intraspecies discrimination of Bordetella avium and Bordetella hinzii. J. Clin. Microbiol. 41: 1512 1519.
83. Register, K. B.,, and T. L. Nicholson. 2007. Misidentification of Bordetella bronchiseptica as Bordetella pertussis using a newly described real-time PCR targeting the pertactin gene. J. Med. Microbiol. 56: 1608 1610.
84. Rehfuss, M.,, and J. Urban. 2005. Alcaligenes faecalis subsp. phenolicus subsp. nov. a phenol-degrading, denitrifying bacterium isolated from a graywater bioprocessor. Syst. Appl. Microbiol. 28: 421 429.
85. Reischl, U.,, N. Lehn,, G. N. Sanden,, and M. J. Loeffelholz. 2001. Real-time PCR assay targeting IS 481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J. Clin. Microbiol. 39: 1963 1966.
85a. Riffelmann, M.,, K. Thiel,, J. Schmetz,, and C. H. Wirsing von Koenig. 2010. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J. Clin. Microbiol. 48: 4459 4463.
86. Riffelmann, M.,, C. H. Wirsing von König,, V. Caro,, and N. Guiso. 2005. Nucleic acid amplification tests for diagnosis of Bordetella infections. J. Clin. Microbiol. 43: 4925 4929.
87. Rønne Hansen, C.,, T. Pressler,, N. Høiby,, and M. Gormsen. 2006. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. J. Cyst. Fibros. 5: 245 251.
88. Saiman, L.,, Y. Chen,, P. San Gabriel,, and C. Knirsch. 2002. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob. Agents Chemother. 46: 1105 1107.
89. Saiman, L.,, Y. Chen,, S. Tabibi,, P. San Gabriel,, J. Zhou,, Z. Liu,, L. Lai,, and S. Whittier. 2001. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J. Clin. Microbiol. 39: 3942 3945.
90. Schroll, G.,, H. J. Busse,, G. Parrer,, S. Rölleke,, W. Lubitz,, and E. B. Denner. 2001. Alcaligenes faecalis subsp. parafaecalis subsp. nov., a bacterium accumulating poly-beta-hydroxybutyrate from acetone-butanol bioprocess residues. Syst. Appl. Microbiol. 24: 37 43.
91. Schwarz, S.,, E. Aleksik,, M. Grobbel,, A. Lübcke-Becker,, C. Werckenthin,, L. H. Wieler,, and J. Wallmann. 2007. Antimicrobial susceptibility of Pasteurella multocida and Bordetella bronchiseptica from dogs and cats as determined in the BfT-GermVet monitoring program 2004-2006. Berl. Munch. Tierarztl. Woschenschr. 120: 423 430.
92. Sebaihia, M.,, A. Preston,, D. J. Maskell,, H. Kuzmiak,, T. D. Connell,, N. D. King,, P. E. Orndorff,, D. M. Miyamoto,, N. R. Thomson,, D. Harris,, A. Goble,, A. Lord,, L. Murphy,, M. A. Quail,, S. Rutter,, R. Squares,, S. Squares,, J. Woodward,, J. Parkhill,, and L. M. Temple. 2006. Comparison of the genome sequence of the poultry pathogen Bordetella avium with those of B. bronchiseptica, B. pertussis and B. parapertussis reveals extensive diversity in surface structures associated with host interaction. J. Bacteriol. 188: 6002 6015.
93. Shelly, D. B.,, T. Spilker,, E. J. Gracely,, T. Coenye,, P. Vandamme,, and J. J. LiPuma. 2000. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J. Clin. Microbiol. 38: 3112 3115.
94. Snyder, J. W.,, G. K. Munier,, and C. L. Johnson. 2008. Direct comparison of the BD Phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms. J. Clin. Microbiol. 46: 2327 2333.
95. Spangler, S. K.,, M. A. Visalli,, M. R. Jacobs,, and P. C. Appelbaum. 1996. Susceptibilities of non- Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. Antimicrob. Agents Chemother. 40: 772 775.
96. Spicuzza, L.,, C. Sciuto,, G. Vitaliti,, G. Di Dio,, S. Leonardi,, and M. La Rosa. 2009. Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur. J. Clin. Microbiol. Infect. Dis. 28: 191 195.
97. Spilker, T.,, A. A. Liwienski,, and J. J. LiPuma. 2008. Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis. Clin. Microbiol. Infect. 14: 504 506.
98. Stark, D.,, L. A. Riley,, J. Harkness,, and D. Mariott. 2007. Bordetella petrii from a clinical sample in Australia: isolation and molecular identification. J. Med. Microbiol. 56: 435 437.
99. Tatti, K. M.,, K. H. Wu,, M. L. Tondella,, P. K. Cassiday,, M. M. Cortese,, P. P. Wilkins,, and G. N. Sanden. 2008. Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp. Diagn. Microbiol. Infect. Dis. 61: 264 272.
100. Templeton, K. E.,, S. A. Scheltinga,, A. van der Zee,, B. M. W. Diederen,, A. M. Kruijssen,, H. Goossens,, E. Kuijper,, and E. C. J. Claas. 2003. Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J. Clin. Microbiol. 41: 4121 4126.
101. Tondella, M. L.,, G. M. Carlone,, N. Messonnier,, C. P. Quinn,, B. D. Meade,, D. L. Burns,, J. D. Cherry,, N. Guiso,, E. L. Hewlett,, K. M. Edwards,, D. Xing,, A. Giammanco,, C. H. Wirsing von König,, L. Han,, L. Hueston,, J. B. Robbins,, M. Powell,, C. M. Mink,, J. T. Poolman,, S. W. Hildreth,, F. Lynn,, and A. Morris. 2009. International Bordetella pertussis assays standardization and harmonization meeting report. Vaccine 27: 803 814.
102. vanAmersfoorth, S. C. M.,, L. S. Schouls,, H. G. J. vanderHeide,, A. Advani,, H. O. Hallander,, K. Bondeson,, C. H. W. vonKönig,, M. Riffelmann,, C. Vahrenholz,, N. Guiso,, V. Caro,, E. Njamkepo,, Q. He,, J. Mertsola,, and F. R. Mooi. 2005. Analysis of Bordetella pertussis populations in European countries with different vaccine policies. J. Clin. Microbiol. 43: 2837 2843.
103. VanDaele, S.,, R. Verhelst,, G. Claeys,, G. Verschraegen,, H. Franckx,, L. VanSimaey,, C. deGanck,, F. DeBaets,, and M. Vaneechoutte. 2005. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center. J. Clin. Microbiol. 43: 2998 3002.
104. Vandamme, P.,, J. Hommez,, M. Vancanneyt,, M. Monsieurs,, B. Hoste,, B. Cookson,, C. H. Wirsing von Konig,, K. Kersters,, and P. J. Blackall. 1995. Bordetella hinzii sp. nov., isolated from poultry and humans. Int. J. Syst. Bacteriol. 45: 37 45.
105. Vandamme, P.,, M. Heyndrickx,, M. Vancanneyt,, B. Hoste,, P. DeVos,, E. Falsen,, K. Kersters,, and K. H. Hinz. 1996. Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Rüger and Tan 1983. Int. J. Syst. Bacteriol. 46: 849 858.
106. VanTrappen, S.,, T. L. Tan,, E. Samyn,, and P. Vandamme. 2005. Alcaligenes aquatilis sp. nov., a novel bacterium from sediments of the Weser Estuary, Germany, and a salt marsh on Shem Creek in Charleston Harbor, USA. Int. J. Syst. Evol. Microbiol. 55: 2571 2575.
107. Versteegh, F. G.,, J. F. Schellekens,, A. F. Nagelkerke,, and J. J. Roord. 2002. Laboratory-confirmed reinfection with Bordetella pertussis. Acta Paediatr. 91: 95 97.
108. Versteegh, F. G.,, P. L. Mertens,, H. E. de Melker,, J. J. Roord,, J. F. Schellekens,, and P. F. Teunis. 2005. Agespecific long-term course of antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol. Infect. 133: 737 748.
109. Von Witzingerode, F.,, A. Schattke,, R. A. Siddiqui,, U. Rösick,, U. B. Göbel,, and R. Gross. 2001. Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. Int. J. Syst. Evol. Microbiol. 51: 1257 1265.
110. Wang, F.,, S. Grundmann,, M. Schmid,, U. Dörfler,, S. Roherer,, J. C. Munch,, A. Hartmann,, X. Jiang,, and R. Schroll. 2007. Isolation and characterization of 1,2,4-trichlorbenzene mineralizing Bordetella sp. and its bioremediation potential in soil. Chemosphere 76: 896 902.
111. Ward, J. I.,, J. D. Cherry,, S. J. Chang,, S. Partridge,, W. Keitel,, K. Edwards,, M. Lee,, J. Treanor,, D. P. Greenberg,, S. Barenkamp,, D. I. Bernstein,, R. Edelman, and the APERT Study Group. 2006. Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults as assessed in a national prospective randomized acellular pertussis vaccine trial (APERT). Clin. Infect. Dis. 43: 151 157.
112. Watanabe, M.,, B. Connelly,, and A. A. Weiss. 2006. Characterization of serological responses to pertussis. Clin. Vaccine Immunol. 13: 341 348.
113. Waters, V.,, F. Jamieson,, S. E. Richardson,, M. Finkelstein,, A. Wormsbecker,, and S. A. Halperin. 2009. Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children. Pediatr. Infect. Dis. J. 28: 582 587.
114. Wellinghausen, N.,, B. Wirths,, and S. Poppert. 2006. Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients. J. Clin. Microbiol. 44: 3415 3417.
115. Wendelboe, A. M.,, M. G. Hudgens,, C. Poole,, and A. van Rie. 2007. Estimating the role of casual contacts from the community in transmission of Bordetella pertussis to young infants. Emerg. Themes Epidemiol. 4: 15.
116. Weyant, R. S.,, D. G. Hollis,, R. E. Weaver,, M. F. Amin,, A. G. Steigerwalt,, S. P. O’Connor,, A. M. Whitney,, M. I. Daneshvar,, C. W. Moss,, and D. J. Brenner. 1995. Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J. Clin. Microbiol. 33: 1 7.
117. Wirsing von König, C. H.,, S. Halperin,, M. Riffelmann,, and N. Guiso. 2002. Pertussis of adults and infants. Lancet Infect. Dis. 2: 744 750.
118. Wright, R. M.,, J. E. Moore,, A. Shaw,, K. Dunbar,, M. Dodd,, K. Webb,, A. O. Redmond,, M. Crowe,, P. G. Murphy,, S. Peacock,, and J. S. Elborn. 2001. Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis. J. Clin. Pathol. 54: 803 805.
119. Xing, D.,, C. H. Wirsing von König,, P. Newland,, M. Riffelmann,, B. D. Meade,, M. Corbel,, and R. Gaines-Das. 2009. Characterization of proposed reference materials for pertussis antiserum (human) by an international collaborative study. Clin. Vaccine Immunol. 16: 303 311.
120. Yabuuchi, E.,, Y. Kawamura,, Y. Kosako,, and T. Ezaki. 1998. Emendation of the genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Rüger and Tan) comb. nov. Microbiol. Immunol. 42: 429 438.
121. Yih, W. K.,, S. M. Lett,, F. N. des Vignes,, K. M. Garrison,, P. L. Sipe,, and C. D. Marchant. 2000. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J. Infect. Dis. 182: 1409 1416.
122. Zbinden, A.,, E. C. Bötåtger,, P. P. Bosshard,, and R. Zbinden. 2007. Evaluation of the colorimetric VITEK 2 card for identification of gram-negative nonfermentative rods: comparison to 16S rRNA gene sequencing. J. Clin. Microbiol. 45: 2270 2273.

Tables

Generic image for table
Table 1

Members of the genus

Citation: Wirsing von König C, Riffelmann M, Coenye T. 2011. and Related Genera, p 739-750. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch43
Generic image for table
Table 2

Biochemical reactions useful for differentiating and species

Data are from references , and .

Symbols and abbreviations: +, ≥90% of the strains are positive; –, ≤10% of the strains are positive; V, 10 to 89% of the strains are positive; ND, not determined.

Citation: Wirsing von König C, Riffelmann M, Coenye T. 2011. and Related Genera, p 739-750. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch43
Generic image for table
Table 3

Useful characteristics for differentiating species

Symbols and abbreviations: +, ≥90% of the strains are positive; –0, ≤10% of the strains are positive; V, 10 to 89% of the strains are positive; ND, not determined.

Citation: Wirsing von König C, Riffelmann M, Coenye T. 2011. and Related Genera, p 739-750. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch43

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error